levonorgestrel has been researched along with Adnexitis in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (15.38) | 18.7374 |
| 1990's | 13 (33.33) | 18.2507 |
| 2000's | 8 (20.51) | 29.6817 |
| 2010's | 12 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronoff, DM; Bassis, CM; Bell, JD; Bergin, IL; Chai, D; Eastman, AJ; LeBar, W; Liechty, ER; Nyachieo, A; Oluoch, GO; Patton, DL; Young, VB | 1 |
| Cherpes, TL; Quispe Calla, NE; Vicetti Miguel, RD | 1 |
| Assouni Mindjah, YA; Dohbit, JS; Essiben, F; Foumane, P; Mboudou, ET | 1 |
| Soper, DE | 1 |
| Apter, D; Gemzell-Danielsson, K; Hauck, B; Nelson, A; Rosen, K; Rybowski, S; Schmelter, T | 1 |
| Aoun, J; Dines, VA; Gomez-Lobo, V; Mete, M; Nelson, CB; Stovall, DW | 1 |
| Bodean, O; Cirstoiu, C; Cirstoiu, M; Munteanu, O; Radulescu, L; Secara, D | 1 |
| Hall, AM; Kutler, BA | 1 |
| Apter, D; Buhling, KJ; Dermout, SM; Gemzell-Danielsson, K; Lukkari-Lax, E; Montegriffo, E | 1 |
| Creinin, MD; Eisenberg, DL; Keder, LM; Teal, SB; Turok, DK | 1 |
| Lohr, P; Lyus, R; Prager, S | 1 |
| Bravender, T; Matson, SC | 1 |
| Haspels, AA; Van Santen, MR | 1 |
| Goldberg, B | 1 |
| Barr, D; Finger, WR | 1 |
| Blacksell, S; Cox, M; Tripp, J | 1 |
| Luukkainen, T; Pakarinen, P; Toivonen, J | 1 |
| Mishell, DR | 1 |
| Heikinheimo, O; Lehtovirta, P; Paavonen, J | 1 |
| Darney, PD; Prager, S | 1 |
| Alvarez, F; Brache, V; Coutinho, E; Diaz, J; Diaz, MM; Diaz, S; el Mahgoub, S; Faundes, A; Pavez, M; Sivin, I | 1 |
| Chi, IC; Farr, G | 1 |
| Andersson, K; Odlind, V; Rybo, G | 1 |
| Chi, IC | 1 |
| Odlind, V | 1 |
| Burkman, RT; Dardano, KL | 1 |
| Odlind, V; Rönnerdag, M | 1 |
| Hogg, B; Keller, PJ; Lebeda, E; Merki-Feld, GS | 1 |
| Achiron, R; Kreizer, D; Soriano, D; Zalel, Y | 1 |
| Andersson, K | 1 |
| Alvarez, F; Brache, V; Coutinho, E; Diaz, S; el Mahgoub, S; Mattos, CE; Pavez, M; Sivin, I; Stern, J; Thevenin, F | 1 |
| Allonen, H; Luukkainen, T; Toivonen, J | 1 |
| Sivin, I | 1 |
| Alvarez, F; Brache, V; Diaz, J; el Mahgoub, S; Faundes, A; Jimenez, E; McCarthy, T; Mishell, DR; Shoupe, D; Sivin, I | 1 |
| Ratsula, K | 2 |
| Coutinho, E; Diaz, J; Diaz, MM; Diaz, S; el Mahgoub, S; Faundes, A; Mattos, CE; Pavez, M; Sivin, I; Stern, J | 1 |
| Digranes, A; Hofstad, T; Sandvei, R; Steier, AJ; Ulstein, M | 1 |
6 review(s) available for levonorgestrel and Adnexitis
| Article | Year |
|---|---|
The levonorgestrel intrauterine system in nulliparous women.
Topics: Abortion, Induced; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Patient Satisfaction; Pelvic Inflammatory Disease; Pregnancy | 2007 |
The non-contraceptive effects of the levonorgestrel-releasing intrauterine device.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic | 1994 |
The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond?
Topics: Evaluation Studies as Topic; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Uterine Perforation | 1993 |
Long-term experience of a levonorgestrel-releasing intrauterine system.
Topics: Contraceptive Agents, Female; Equipment Failure; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Risk Factors; Uterine Hemorrhage | 1996 |
The intrauterine contraceptive device: an often-forgotten and maligned method of contraception.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Inflammatory Disease | 1999 |
The levonorgestrel intrauterine system: more than a contraceptive.
Topics: Administration, Intravaginal; Adult; Endometrium; Equipment Design; Female; Humans; Levonorgestrel; Pelvic Inflammatory Disease; Randomized Controlled Trials as Topic | 2001 |
12 trial(s) available for levonorgestrel and Adnexitis
| Article | Year |
|---|---|
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial.
Topics: Adolescent; Adult; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Rate; Pregnancy, Unplanned; Uterine Perforation; Young Adult | 2013 |
A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents.
Topics: Adolescent; Child; Contraceptive Agents, Female; Device Removal; Europe; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Patient Satisfaction; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Pregnancy, Unplanned; Uterine Perforation | 2016 |
Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report.
Topics: Adult; Device Removal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Rate; Progesterone Congeners; United Kingdom; Uterine Hemorrhage | 2002 |
Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up.
Topics: Abortion, Induced; Adult; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Pain; Pelvic Inflammatory Disease; Pregnancy; Uterine Hemorrhage | 2003 |
Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Menstrual Cycle; Norgestrel; Pelvic Inflammatory Disease; Pregnancy | 1984 |
The non-contraceptive effects of the levonorgestrel-releasing intrauterine device.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic | 1994 |
Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
Topics: Adult; Contraceptive Agents, Female; Drug Monitoring; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Pelvic Inflammatory Disease; Postmenopause; Pregnancy; Regression Analysis | 1999 |
Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
Topics: Adolescent; Adult; Endometriosis; Female; Hemoglobins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menstruation Disturbances; Patient Dropouts; Pelvic Inflammatory Disease | 1991 |
Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Norgestrel; Pelvic Inflammatory Disease; Random Allocation | 1991 |
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Topics: Adolescent; Adult; Amenorrhea; Copper; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Norgestrel; Patient Dropouts; Pelvic Inflammatory Disease | 1990 |
Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pain; Pelvic Inflammatory Disease; Pregnancy; Random Allocation | 1987 |
Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
Topics: Adolescent; Adult; Cervix Uteri; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pelvic Inflammatory Disease; Prospective Studies; Random Allocation; Risk Factors; Vagina | 1987 |
22 other study(ies) available for levonorgestrel and Adnexitis
| Article | Year |
|---|---|
Impact of the Levonorgestrel-Releasing Intrauterine System on the Progression of Chlamydia trachomatis Infection to Pelvic Inflammatory Disease in a Baboon Model.
Topics: Animals; Antibodies, Bacterial; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Contraceptive Agents, Female; Cytokines; Disease Models, Animal; Disease Progression; Fallopian Tubes; Female; Intrauterine Devices; Levonorgestrel; Papio; Pelvic Inflammatory Disease; Sexually Transmitted Diseases, Bacterial; Vagina | 2018 |
Levonorgestrel and Female Genital Tract Immunity: Time for a Closer Look.
Topics: Animals; Chlamydia Infections; Chlamydia trachomatis; Female; Genitalia, Female; Humans; Levonorgestrel; Papio; Pelvic Inflammatory Disease | 2018 |
Risk factors for ectopic pregnancy in a population of Cameroonian women: A case-control study.
Topics: Adolescent; Adult; Cameroon; Case-Control Studies; Contraception, Postcoital; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Odds Ratio; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Risk Factors; Young Adult | 2018 |
The intrauterine device: a good thing revisited.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Biomedical Research; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Metrorrhagia; Pelvic Inflammatory Disease; Tamoxifen; Tranexamic Acid | 2013 |
Effects of age, parity, and device type on complications and discontinuation of intrauterine devices.
Topics: Adolescent; Adult; Age Factors; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Patient Acceptance of Health Care; Pelvic Inflammatory Disease; Pregnancy; Retrospective Studies; Young Adult | 2014 |
Is antibiotic prophylaxis mandatory after the insertion of levonorgestrel-releasing intrauterine systemin order to decrease the risk of pelvic inflammatory disease?
Topics: Adult; Antibiotic Prophylaxis; Female; Humans; Intrauterine Devices; Levonorgestrel; Pelvic Inflammatory Disease; Prospective Studies | 2013 |
Intrauterine contraception in nulliparous women: a prospective survey.
Topics: Adult; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Acceptance of Health Care; Patient Satisfaction; Pelvic Inflammatory Disease; Young Adult | 2016 |
A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.
Topics: Adolescent; Adult; Chlamydia Infections; Contraceptive Agents, Female; Endometritis; Female; Gonorrhea; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pelvic Infection; Pelvic Inflammatory Disease; Prospective Studies; Randomized Controlled Trials as Topic; Sexually Transmitted Diseases; Time Factors; Young Adult | 2016 |
Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.
Topics: Adolescent; Contraceptive Agents, Female; Female; Humans; Infertility, Female; Intrauterine Devices, Copper; Levonorgestrel; Parity; Pelvic Inflammatory Disease; Pregnancy; Uterine Perforation | 2010 |
Adolescents, IUDs, PID, and Enterococcus: a report of two cases.
Topics: Adolescent; Contraceptive Agents, Female; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Inflammatory Disease; Young Adult | 2012 |
Post coital contraception.
Topics: Biology; Birth Rate; Breast; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Developed Countries; Digestive System; Disease; Embryo Implantation; Embryonic Development; Endocrine System; Ethics; Ethinyl Estradiol; Europe; Family Planning Services; Fertility; Hormones; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Nausea; Netherlands; Parity; Pelvic Inflammatory Disease; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy, Ectopic; Reproduction; Signs and Symptoms; Vomiting | 1986 |
Reconsidering IUDs.
Topics: Americas; Congresses as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Family Planning Services; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; North America; Pelvic Inflammatory Disease; United States | 1992 |
Acceptability of IUDs is increasing.
Topics: Americas; Behavior; Community Health Workers; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Cost-Benefit Analysis; Decision Making; Developed Countries; Disease; Evaluation Studies as Topic; Family Planning Services; Health Planning; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; North America; Patient Acceptance of Health Care; Pelvic Inflammatory Disease; Postnatal Care; United States | 1992 |
Intrauterine contraception: benefits to patients.
Topics: Adult; Attitude of Health Personnel; Copper; Female; Humans; Intrauterine Devices; Levonorgestrel; Pelvic Inflammatory Disease; Randomized Controlled Trials as Topic; United States | 2004 |
Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
Topics: Adult; Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menorrhagia; Menstruation; Middle Aged; Pelvic Inflammatory Disease; Safety; Treatment Outcome; Virus Shedding | 2007 |
Hormonal intrauterine devices.
Topics: Adolescent; Adult; Amenorrhea; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pelvic Inflammatory Disease; Pregnancy; Sweden; Uterine Hemorrhage | 1993 |
The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices.
Topics: Actinomyces; Actinomycosis; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Papanicolaou Test; Pelvic Inflammatory Disease; Vaginal Smears | 2000 |
[Sonographic demonstration of a levonorgestrel-releasing IUD (Mirena)].
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Pelvic Inflammatory Disease; Pregnancy; Ultrasonography | 1999 |
Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health.
Topics: Abdominal Pain; Adult; Breast Neoplasms; Contraceptive Agents, Female; Developing Countries; Drug Implants; Female; Fertility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Marital Status; Ovarian Cysts; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Product Surveillance, Postmarketing; Prospective Studies; Sterilization, Tubal; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms; Vaginal Discharge; Vaginitis | 2001 |
Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Pelvic Inflammatory Disease | 1991 |
Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first two years of use.
Topics: Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Patient Compliance; Pelvic Inflammatory Disease; Pregnancy | 1989 |
Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.
Topics: Adult; Carbamazepine; Cervix Uteri; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Norgestrel; Pelvic Inflammatory Disease; Pregnancy | 1987 |